• English

    Google Translate Disclaimer

    The Maryland Department of Information Technology (“DoIT”) offers translations of the content through Google Translate. Because Google Translate is an external website, DoIT does not control the quality or accuracy of translated content. All DoIT content is filtered through Google Translate which may result in unexpected and unpredictable degradation of portions of text, images and the general appearance on translated pages. Google Translate may maintain unique privacy and use policies. These policies are not controlled by DoIT and are not associated with DoIT’s privacy and use policies. After selecting a translation option, users will be notified that they are leaving DoIT’s website. Users should consult the original English content on DoIT’s website if there are any questions about the translated content.

    DoIT uses Google Translate to provide language translations of its content. Google Translate is a free, automated service that relies on data and technology to provide its translations. The Google Translate feature is provided for informational purposes only. Translations cannot be guaranteed as exact or without the inclusion of incorrect or inappropriate language. Google Translate is a third-party service and site users will be leaving DoIT to utilize translated content. As such, DoIT does not guarantee and does not accept responsibility for, the accuracy, reliability, or performance of this service nor the limitations provided by this service, such as the inability to translate specific files like PDFs and graphics (e.g. .jpgs, .gifs, etc.).

    DoIT provides Google Translate as an online tool for its users, but DoIT does not directly endorse the website or imply that it is the only solution available to users. All site visitors may choose to use alternate tools for their translation needs. Any individuals or parties that use DoIT content in translated form, whether by Google Translate or by any other translation services, do so at their own risk. DoIT is not liable for any loss or damages arising out of, or issues related to, the use of or reliance on translated content. DoIT assumes no liability for any site visitor’s activities in connection with use of the Google Translate functionality or content.

    The Google Translate service is a means by which DoIT offers translations of content and is meant solely for the convenience of non-English speaking users of the website. The translated content is provided directly and dynamically by Google; DoIT has no direct control over the translated content as it appears using this tool. Therefore, in all contexts, the English content, as directly provided by DoIT is to be held authoritative.

    ​​Center for H​​a​​​​​​​​​rm ​
    ​Redu​ction Serv​ice​​s​​​​

    The Maryland Department of Health ​Center for H​arm Reduction Services ​(CHRS) ​was established in 2019 to centralize harm reduction activities across the Department. The Center is housed with the Infectious Disease Prevention and Health Services Bureau in the Prevention and Health Promotion Administration. The Center oversees the Overdose Response Program, Syringe Services Program, naloxone distribution, harm reduction grants​, and various workforce development, training, and technical assistance activities.​​​​​

    ​​​CHRS ​Strategic Goa​​​l and​​​ V​​isi​​​​​​​on​​​​

    ​​​The Center's strategic goal is to​​​ reduce substance-related morbidity and mortality by optimizing services for people who use drugs. ​The Center for Harm Reduction Services envisions a Maryland where:
    • People who use drugs have access to compassionate, quality care that is free from stigma;
    • Services are low-barrier, community-based, and comprehensive; and
    • Experiences of past trauma, criminal legal involvement, and racism do not determine one’s health outcomes or quality of life.​
    ​​​ ​

    FY23 ACCES​​S ​​Ha​​rm Reduction​​ Request for Applications​

    ​​The SFY23 ACCESS Harm Reduction Grant Request for Applications is open for submissions until 2:00PM on April 25, 2022. 501(c)(3) nonprofits ​ may apply.

    Please note: grants we be made available to Local Health Departments through a separate solicitation-- stay tuned!

    This solicitation will fund direct services and c​apacity-building initiatives that use a harm reduction framework to add​ress adverse health outcomes for people who use drugs.

    ​​​Allowable Costs​​​​

    ​​Naloxone kit materials such as bags,​ face shields, & brochures
    ​Rapid tests for HIV, HCV, syphilis, and COVID-19
    ​Safer injection supplies​Fentanyl test strips
    ​Wound care supplies​​​Staff salary and ​training​
    ​Syringe disposal kiosksAnd mor​e!

    Important Dates​​​

    April 12, 2022, 9:30-11:00AM

    Join the pre-application webinar by Google Meet​ or by phone: 1(405)-355-2356‬, PIN: ‪424 182 039‬#

    2:00PM April 25, 2022

    Submissions due.

    SFY23 - SFY24

    ​The funding period will be July 1, 2022 - June 30, 2023 with optional extension period July 1, 2023 – Jun​e 30, 2024​.


    ​​New St​atewide​​ Stan​ding ​​Order​​ for Pharmacy Dispensin​g

    The statewide standing order​​ issued by Dr. Jinlene Chan, MD, MPH, Deputy Secretary for Public Health, Maryland Department of Health (MDH), allows all Maryland licensed pharm​acists to dispense naloxone, including any necessary supplies for administration, to any individual.

    Pharmacists may dispense naloxone to anyone, regardless of whether the person has previously been trained under ORP or received training in opioid overdose response.

    ​The standing order issued June 1, 2021 is effective until June 1, 2023, at which time a new order will be issued.


    Download the n​aloxone standing order for pharmacy dispensing.​​

    COVID-19 ​​and Harm ​​Reduction Information and R​​esources​

    ​​​​​​Please click here​ for COVID-19 resources and i​nformation for harm reduction programs.

    Overdose​ Resp​onse Progra​​m

    The Center for Harm Reduction Serv​ices authorizes government agencies and community-based organizations as Over​dose Response Programs, allowing them to provide overdose education and dispense naloxone to the community.​ Please contact mdh.naloxone@maryland.gov with any questions.

    Syringe Service​s Progra​ms

    The Center for Harm Reduction administers the Maryland Syringe Services Program, reviewing new applications, managing program reporting, issuing program guidance, and providing TA and support to approved programs. The Center for Harm Reduction Services also holds quarterly meetings of the Standing Advisory Committee on Opioid-Associated Disease Prevention and Outreach. These meetings are open to the public. Please contact mdh.syringeservices@maryland.gov with any questions.

    CHRS Grants and Res​ourc​​es​

    Through our grant programs​, the Center for Harm Reduction Services supports the local i​mplementation of harm reduction programs and ensures statewide access to resources for harm reduction activities including naloxone. ​These grants support the CHRS goals of reducing substance-related morbidity and mortality by optimizing services for people who use drugs. Please contact mdh.access@maryland.gov​ with any questions.

    ​ ​

    ​​​​Training ​and Tec​​hnica​l ​Ass​istance​

    The Maryland Department of Health, Center for Harm Reduction Services partners ​with the Maryland Harm Reduction Training Institute (MaHRTI)​ to build the capacity of Maryland's harm reduction workforce to provide optimal services to people who use drugs. For more information, visit mahrti.thinkific.com​ or contact mahrti@bhsbaltimore.org. The Center also provides other workforce development and training, including the Regrounding Our Response initiative and Law Enforcement Assisted Diversion training.

    Contact Us​​​

    ​​Please email:​

    ​​​​​Naloxone and Overdose Response Progr​​​ams

    ​Grants, fiscal questio​ns, and resources requests
    Syringe Services Programs​


    ​​​​Center for Harm
    ​Reduction Services